News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ensemble Therapeutics Corporation Achieves Milestone in Bristol-Myers Squibb Company (BMY) Collaboration



4/12/2011 8:40:15 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the power of biologics, today announced that it has achieved an important milestone in its research collaboration with Bristol-Myers Squibb Company (NYSE:BMY) by successfully developing Ensemblins against one of the designated key drug targets, resulting in an undisclosed milestone payment to Ensemble.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES